Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Multi-Component Herbal Products in the Prevention and Treatment of Chemotherapy-Associated Toxicity and Side Effects: A Review on Experimental and Clinical Evidences.

Fu B, Wang N, Tan HY, Li S, Cheung F, Feng Y.

Front Pharmacol. 2018 Nov 29;9:1394. doi: 10.3389/fphar.2018.01394. eCollection 2018. Review.

2.

Moxibustion for alleviating side effects of chemotherapy or radiotherapy in people with cancer.

Zhang HW, Lin ZX, Cheung F, Cho WC, Tang JL.

Cochrane Database Syst Rev. 2018 Nov 13;11:CD010559. doi: 10.1002/14651858.CD010559.pub2.

PMID:
30480754
3.

The Potential and Action Mechanism of Polyphenols in the Treatment of Liver Diseases.

Li S, Tan HY, Wang N, Cheung F, Hong M, Feng Y.

Oxid Med Cell Longev. 2018 Feb 4;2018:8394818. doi: 10.1155/2018/8394818. eCollection 2018. Review.

4.

Network Pharmacology-Based Approach to Investigate the Analgesic Efficacy and Molecular Targets of Xuangui Dropping Pill for Treating Primary Dysmenorrhea.

Huang J, Li L, Cheung F, Wang N, Li Y, Fan Z, Yin F, Yang J, Gao R, He Y, Feng Y.

Evid Based Complement Alternat Med. 2017;2017:7525179. doi: 10.1155/2017/7525179. Epub 2017 Oct 8.

5.

Identification of the active compounds and significant pathways of yinchenhao decoction based on network pharmacology.

Huang J, Cheung F, Tan HY, Hong M, Wang N, Yang J, Feng Y, Zheng Q.

Mol Med Rep. 2017 Oct;16(4):4583-4592. doi: 10.3892/mmr.2017.7149. Epub 2017 Aug 2.

6.

A Network-Based Pharmacology Study of the Herb-Induced Liver Injury Potential of Traditional Hepatoprotective Chinese Herbal Medicines.

Hong M, Li S, Tan HY, Cheung F, Wang N, Huang J, Feng Y.

Molecules. 2017 Apr 14;22(4). pii: E632. doi: 10.3390/molecules22040632.

7.
8.

Cancer Stem Cells: The Potential Targets of Chinese Medicines and Their Active Compounds.

Hong M, Tan HY, Li S, Cheung F, Wang N, Nagamatsu T, Feng Y.

Int J Mol Sci. 2016 Jun 7;17(6). pii: E893. doi: 10.3390/ijms17060893. Review.

9.

Substitutes for Bear Bile for the Treatment of Liver Diseases: Research Progress and Future Perspective.

Li S, Tan HY, Wang N, Hong M, Li L, Cheung F, Feng Y.

Evid Based Complement Alternat Med. 2016;2016:4305074. doi: 10.1155/2016/4305074. Epub 2016 Mar 21. Review.

10.

Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities.

Lam P, Cheung F, Tan HY, Wang N, Yuen MF, Feng Y.

Int J Mol Sci. 2016 Mar 29;17(4):465. doi: 10.3390/ijms17040465. Review.

11.

Preclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and Perspective.

Tan HY, San-Marina S, Wang N, Hong M, Li S, Li L, Cheung F, Wen XY, Feng Y.

Evid Based Complement Alternat Med. 2016;2016:4750163. doi: 10.1155/2016/4750163. Epub 2016 Jan 28. Review.

12.

Chinese medicines for prevention and treatment of human hepatocellular carcinoma: current progress on pharmacological actions and mechanisms.

Wang X, Wang N, Cheung F, Lao L, Li C, Feng Y.

J Integr Med. 2015 May;13(3):142-64. doi: 10.1016/S2095-4964(15)60171-6. Review.

PMID:
26006028
13.

Inhibition of eukaryotic elongation factor-2 confers to tumor suppression by a herbal formulation Huanglian-Jiedu decoction in human hepatocellular carcinoma.

Wang N, Feng Y, Tan HY, Cheung F, Hong M, Lao L, Nagamatsu T.

J Ethnopharmacol. 2015 Apr 22;164:309-18. doi: 10.1016/j.jep.2015.02.025. Epub 2015 Feb 17.

PMID:
25700642
14.

Chinese medicines induce cell death: the molecular and cellular mechanisms for cancer therapy.

Wang X, Feng Y, Wang N, Cheung F, Tan HY, Zhong S, Li C, Kobayashi S.

Biomed Res Int. 2014;2014:530342. doi: 10.1155/2014/530342. Epub 2014 Oct 14. Review.

15.

A Chinese medicine formula Gegen Qinlian decoction suppresses expansion of human renal carcinoma with inhibition of matrix metalloproteinase-2.

Wang N, Feng Y, Cheung F, Wang X, Zhang Z, Feng Y.

Integr Cancer Ther. 2015 Jan;14(1):75-85. doi: 10.1177/1534735414550036. Epub 2014 Sep 15.

PMID:
25228536
16.

Chinese Medicines as an Adjuvant Therapy for Unresectable Hepatocellular Carcinoma during Transarterial Chemoembolization: A Meta-Analysis of Randomized Controlled Trials.

Cheung F, Wang X, Wang N, Yuen MF, Ziea TC, Tong Y, Wong VT, Feng Y.

Evid Based Complement Alternat Med. 2013;2013:487919. doi: 10.1155/2013/487919. Epub 2013 Jul 17.

17.

A comparative study on the hepatoprotective action of bear bile and Coptidis Rhizoma aqueous extract on experimental liver fibrosis in rats.

Wang N, Feng Y, Cheung F, Chow OY, Wang X, Su W, Tong Y.

BMC Complement Altern Med. 2012 Nov 29;12:239. doi: 10.1186/1472-6882-12-239.

18.

Recent progress on anti-liver fibrosis candidates in patents of herbal medicinal products.

Wang XB, Feng Y, Wang N, Cheung F, Wong CW.

Recent Pat Food Nutr Agric. 2012 Aug;4(2):91-106. Review.

PMID:
22594662
19.

Effectiveness of Chinese herbal medicine in treating liver fibrosis: a systematic review and meta-analysis of randomized controlled trials.

Cheung F, Feng Y, Wang N, Yuen MF, Tong Y, Wong VT.

Chin Med. 2012 Feb 29;7(1):5. doi: 10.1186/1749-8546-7-5.

20.

Hepatoprotective effect and its possible mechanism of Coptidis rhizoma aqueous extract on carbon tetrachloride-induced chronic liver hepatotoxicity in rats.

Feng Y, Wang N, Ye X, Li H, Feng Y, Cheung F, Nagamatsu T.

J Ethnopharmacol. 2011 Dec 8;138(3):683-90. doi: 10.1016/j.jep.2011.09.032. Epub 2011 Sep 22.

PMID:
21963555

Supplemental Content

Loading ...
Support Center